Advertisement

Medical Microbiology and Immunology

, Volume 157, Issue 4, pp 335–345 | Cite as

Virusinfizierte Lymphoblasten als Antigen für die Herstellung von heterologen Antilymphocytenseren

  • G. Bandlow
  • F. Kieling
  • R. Thomssen
Article

Zusammenfassung

Nach aktiver Immunisierung mit virusinfizierten Lymphoblasten bilden Meerschweinchen vermehrt Antikörper gegen Antigene nicht infizierter Lymphocyten. Dieser immunologische Adjuvanseffekt wurde nach Infektion von menschlichen und Mäuselymphoblasten mit Herpes simplex-Virus, VSV und Vacciniavirus beobachtet. Die vermehrt gebildeten Antikörper wurden im Mikrolymphocytotoxicitätstest in vitro und in vivo durch ihre immunsuppressive Wirkung bei Tumorverpflanzung (Mastocytoma P-815-x2 DBA/2 → NMRI) nachgewiesen.

Virus infected lymphoblasts acting as antigen for the production of heterologous antilymphocyte sera

Summary

After active immunisation with virus infected lymphoblasts the production of guinea pig antibodies against antigens of not infected lymphocytes is increased. This immunological adjuvant effect was observed when human and mice lymphocytes were infected with herpes simplex virus, VSV and vacciniavirus. The increased production of antibodies was demonstrated by an in vitro micro-lymphocytotoxicitytest and in vivo by its immunsuppressive effect when allogeneic tumor cells (Mastocytoma P-815-x2 DBA/2→NMRI) were transplanted.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bandlow, G., Fischer, W., Thomssen, R.: Untersuchungen zum Mechanismus der immunologischen Adjuvanswirkung des Vacciniavirus. Arch. ges. Virus-forsch. (im Druck).Google Scholar
  2. 2.
    , Kieling, F., Thomssen, R.: Viren als immunologische Adjuvantien für die Produktion von Antikörpern gegen Wirtszellantigene. Arch. ges. Virusforsch.34, 287 (1971).PubMedGoogle Scholar
  3. 3.
    Bouroncle, B. A., Clausen, K. P., Darner, E. M.: Replication of herpes simplex virus in cultures of phythemagglutinin-stimulated human lymphocytes. J. nat. Cancer Inst.44, 1065 (1970).PubMedGoogle Scholar
  4. 4.
    Bremberg, S., Klein, E., Stjernswärd, J.: Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Cancer Res.27, 2113 (1967).PubMedGoogle Scholar
  5. 5.
    Brunner, K. T., Mauel, J., Cerottini, J. C., Chapins, B.: Quantitative assay of the lytic action of lymphoid cells on51Cr labelled allogenic target cells in vitro, inhibition by isoantibody and by drugs. Immunology14, 181 (1967).Google Scholar
  6. 6.
    Chalmers, D. G., Cooper, E. H., Coulson, A. S., Inman, D. R., Topping, N. E.: Immunologically stimulated human peripheral blood lymphocytes in vitro. I. Morphological changes. Int. Arch. Allergy30, 83 (1966).PubMedGoogle Scholar
  7. 7.
    Chessin, L. N., Borjeson, J., Welsh, P. D., Douglas, S. D., Cooper, H. L.: Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J. exp. Med.124, 873 (1966).PubMedGoogle Scholar
  8. 8.
    Dunn, T. B., Potter, M.: A transplantable mast-cell neoplasm in the mouse. J. nat. Cancer Inst.18, 587 (1957).PubMedGoogle Scholar
  9. 9.
    Edelman, R., Wheelock, E.: Vesicular stomatitis virus replication in human leukocyte cultures: Enhancement by phythemagglutinin. Science153, 1053 (1966).Google Scholar
  10. 10.
    Gresser, I., Chany, C.: Multiplication of poliovirus Type I in preparations of human leukocytes and its inhibition by interferon. J. Immunol.92, 889 (1964).PubMedGoogle Scholar
  11. 11.
    Hadházy, G., Gergely, L., Toth, F. D., Szegedi, G.: Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects. Acta microbiol. Acad. Sci. hung.14, 391 (1967).PubMedGoogle Scholar
  12. 12.
    Hook, W. A., Chirigos, M. A., Chan, S. P.: Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum. Cancer Res.29, 1008 (1969).PubMedGoogle Scholar
  13. 13.
    Kissmeyer-Nielsen, F., Boyum, A., Joysey, V.: Micro Lymphocytotoxicity Test. Eurotransplant 1969.Google Scholar
  14. 14.
    Lundgren, G., Möller, G.: Non-specific induction of cytotoxity in normal human lymphocytes in vitro. Studies on the mechanism and specifity of the reaction. Clin. exp. Immunol.4, 435 (1969).PubMedGoogle Scholar
  15. 15.
    Mc.Kenzie, I. F. C., Morris, P. J., Schiff, P., et al.: Human antilymphocytic serum: I. Production and in vitro testing. Med. J. Aust.56, 203 (1969).Google Scholar
  16. 16.
    Medawar, P. B.: Biological effects of heterologous antilymphocyte sera. In: Human transplantation, p. 501. New York-London: Grune u. Stratton 1968.Google Scholar
  17. 17.
    Miller, G., Enders, J. F.: Vaccina virus replication and cytopathic effect in cultures of phythemagglutinin-treated human peripheral blood leukocytes. J. Virol.2, 787 (1968).PubMedGoogle Scholar
  18. 18.
    Nahmias, A. J., Kitrick, S., Rosan, R. C.: Viral leukocyte interrelationship. I. Multiplication of a DNA virus-Herpes Simplex in human leukocyte cultures. J. Immunol.93, 69 (1964).PubMedGoogle Scholar
  19. 19.
    Najarian, J. S., Merkel, F. K., Moore, G. E., Good, R. A., Aust, J. C.: Clinical use of antilymphoblast serum. Transplant. Proc.1969 II, 460.Google Scholar
  20. 20.
    Phillips, S. M., Zweiman, B.: Characteristic of the in vitro response of guinea pig blood lymphocytes to PHA and antigen. J. Immunol.105, 204 (1970).PubMedGoogle Scholar
  21. 21.
    Rexvillard, J. P.: Cell-mediated immunity. In vitro correlates. Basel: Karger 1971.Google Scholar
  22. 22.
    Southworth, J., Ohanian, S. H., Plate, J. M., Amos, D. B.: Heterologous antihuman and antimouse sera prepared in horse, goat, rabbit and cow. Fed. Proc.29, 101 (1970).PubMedGoogle Scholar
  23. 23.
    Starzl, T. E., Marchioro, T. L., Porter, K. A., Iwasaki, Y., Cerilli, G. J.: The use of heterologous antilympoid agents in canine renal and liver homotransplantation, and in human renal homotransplantation. Surg. Gynec. Obstet.124, 301 (1967).PubMedGoogle Scholar
  24. 24.
    Strander, H., Cantell, K.: Production of interferon by human leukocytes in vitro. Ann. Med. exp. Fenn.44, 265 (1966).PubMedGoogle Scholar
  25. 25.
    Traeger, J., Fries, D., Revillard, J. P., Durix, A., Carraz, M., Plan, M.: Production of human antilymphocytic serum in horse with thoracic duct lymphocytes and peripheral blood lymphocytes. Fed. Proc.29, 108 (1970).PubMedGoogle Scholar
  26. 26.
    Wagner, J. L., Haughton, G.: Immunosuppression by antilymphocyte serum and its effect on tumors induced by 3-Methycholanthrene in mice. J. nat. Cancer Inst.46, 1 (1971).PubMedGoogle Scholar
  27. 27.
    Willems, F. T., Melnick, J. L., Rawls, W. E.: Replication of poliovirus in phythemagglutinin stimulated human lymphocytes. J. Virol.3, 451 (1969).PubMedGoogle Scholar
  28. 28.
    Woodruff, M. F. A., Anderson, N. F.: Effect of lympocyte depletion by thoracic duct fistula and administration of antilympocyte serum on the survival of skin homograft in rats. Nature (Lond.)200, 702 (1963).Google Scholar

Copyright information

© Springer-Verlag 1972

Authors and Affiliations

  • G. Bandlow
    • 1
  • F. Kieling
    • 1
  • R. Thomssen
    • 1
  1. 1.Hygiene-Institut der Universität GöttingenDeutschland

Personalised recommendations